504 filings
Page 6 of 26
10-Q
2021 Q1
ATOS
Atossa Therapeutics Inc
Quarterly report
14 May 21
9:47am
8-K
ATOS
Atossa Therapeutics Inc
14 May 21
Atossa Therapeutics Announces First Quarter 2021 Financial Results and Provides Corporate Update
9:15am
DEFA14A
ATOS
Atossa Therapeutics Inc
11 May 21
Additional proxy soliciting materials
4:07pm
EFFECT
ATOS
Atossa Therapeutics Inc
30 Apr 21
Notice of effectiveness
12:15am
CORRESP
ATOS
Atossa Therapeutics Inc
27 Apr 21
Correspondence with SEC
12:00am
UPLOAD
ATOS
Atossa Therapeutics Inc
26 Apr 21
Letter from SEC
12:00am
S-3
ATOS
Atossa Therapeutics Inc
Shelf registration
21 Apr 21
4:27pm
DEF 14A
ATOS
Atossa Therapeutics Inc
Definitive proxy
15 Apr 21
4:00pm
PRE 14A
ATOS
Atossa Therapeutics Inc
Preliminary proxy
5 Apr 21
4:05pm
S-8
ATOS
Atossa Therapeutics Inc
31 Mar 21
Registration of securities for employees
2:30pm
10-K
2020 FY
ATOS
Atossa Therapeutics Inc
Annual report
31 Mar 21
9:05am
8-K
ATOS
Atossa Therapeutics Inc
31 Mar 21
Atossa Therapeutics Announces Year End 2020 Financial Results and Provides Corporate Update
9:01am
424B5
ATOS
Atossa Therapeutics Inc
23 Mar 21
Prospectus supplement for primary offering
7:01am
8-K
ATOS
Atossa Therapeutics Inc
23 Mar 21
Entry into a Material Definitive Agreement
6:01am
S-3MEF
ATOS
Atossa Therapeutics Inc
22 Mar 21
Registration of additional securities for an S-3
7:30am
8-K
ATOS
Atossa Therapeutics Inc
22 Mar 21
Termination of a Material Definitive Agreement
7:00am
424B2
ATOS
Atossa Therapeutics Inc
4 Feb 21
Prospectus for primary offering
4:16pm
EFFECT
ATOS
Atossa Therapeutics Inc
1 Feb 21
Notice of effectiveness
12:15am
UPLOAD
ATOS
Atossa Therapeutics Inc
28 Jan 21
Letter from SEC
12:00am
CORRESP
ATOS
Atossa Therapeutics Inc
28 Jan 21
Correspondence with SEC
12:00am